Proton therapy in clinical practice: Current clinical evidence

Journal of Clinical Oncology

Volumn 25, Issue 8, 2007, Pages 965-970

  Brada, Michael ^a   Pijls Johannesma, Madelon ^a   De Ruysscher, Dirk ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; PROTON; RUTHENIUM 106;

BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CHONDROBLASTOMA; CHONDROSARCOMA; CHORDOMA; CINAHL; CLINICAL PRACTICE; COCHRANE LIBRARY; DISEASE FREE SURVIVAL; DOSIMETRY; EMBASE; ESOPHAGUS TUMOR; EVIDENCE BASED PRACTICE; EYE TUMOR; GIANT CELL TUMOR; HEAD AND NECK CANCER; HUMAN; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; METHODOLOGY; OSTEOBLASTOMA; OSTEOSARCOMA; OUTCOME VARIABLE; PHOTON THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; PROTON THERAPY; RADIATION DOSE; RETROSPECTIVE STUDY; REVIEW; SKULL BASE TUMOR; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT PLANNING; TUMOR GROWTH; HEAD AND NECK TUMOR; MALE; NEOPLASM; PROSTATE TUMOR;

CHONDROSARCOMA; CHORDOMA; EYE NEOPLASMS; HEAD AND NECK NEOPLASMS; HUMANS; MALE; NEOPLASMS; PROSTATIC NEOPLASMS; PROTONS; SKULL BASE NEOPLASMS;

EID: 33947509908     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.10.0131     Document Type: Review

References (84)

1. Schneider U, Lomax A, Lombriser N: Comparative risk assessment of secondary cancer incidence after treatment of Hodgkin's disease with photon and proton radiation. Radiat Res 154:382-388, 2000
2. Miralbell R, Crowell C, Suit HD: Potential improvement of three dimension treatment planning and proton therapy in the outcome of maxillary sinus cancer. Int J Radiat Oncol Biol Phys 22:305-310, 1992
3. Zurlo A, Lomax A, Hoess A, et al: The role of proton therapy in the treatment of large irradiation volumes: A comparative planning study of pancreatic and biliary tumors. Int J Radiat Oncol Biol Phys 48:277-288, 2000
4. Baumert BG, Lomax AJ, Miltchev V, et al: A comparison of dose distributions of proton and photon beams in stereotactic conformal radiotherapy of brain lesions. Int J Radiat Oncol Biol Phys 49:1439-1449, 2001
5. Cozzi L, Fogliata A, Lomax A, et al: A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. Radiother Oncol 61:287-297, 2001
6. Miralbell R, Lomax A, Russo M: Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuro-ectodermal tumors: Spinal theca irradiation. Int J Radiat Oncol Biol Phys 38:805-811, 1997
7. Lee CH, Tait D, Nahum AE, et al: Comparison of proton therapy and conformal X-ray therapy in non-small cell lung cancer (NSCLC). Br J Radiol 72:1078-1084, 1999
8. Fogliata A, Bolsi A, Cozzi L: Critical appraisal of treatment techniques based on conventional photon beams, intensity modulated photon beams and proton beams for therapy of intact breast. Radiother Oncol 62:137-145, 2002
9. Isacsson U, Lennernas B, Grusell E, et al: Comparative treatment planning between proton and x-ray therapy in esophageal cancer. Int J Radiat Oncol Biol Phys 41:441-450, 1998
10. Isacsson U, Hagberg H, Johansson KA, et al: Potential advantages of protons over conventional radiation beams for paraspinal tumours. Radiother Oncol 45:63-70, 1997
11. Isacsson U, Montelius A, Jung B, et al: Comparative treatment planning between proton and X-ray therapy in locally advanced rectal cancer. Radiother Oncol 41:263-272, 1996
12. Pijls-Johannesma M, Lodge M, Stirk L, et al: A systematic literature review of the clinical and cost effectiveness of hadron therapy in cancer. Radiother Oncol 81:S81, 2006 (suppl 1)
13. Lodge M, Pijls-Johannesma M, Stirk L, et al: A systematic literature review of the clinical and cost effectiveness of hadron therapy in cancer. Radiother Oncol (in press)
14. Slater JD, Rossi CJ Jr, Yonemoto LT, et al: Proton therapy for prostate cancer: The initial Loma Linda University experience. Int J Radiat Oncol Biol Phys 59:348-352, 2004
15. Tokuuye K, Akine Y, Kagei K, et al: Proton therapy for head and neck malignancies at Tsukuba. Strahlenther Onkol 180:96-101, 2004
16. Shipley WU, Verhey LJ, Munzenrider JE, et al: Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 32:3-12, 1995
17. Zietman AL, DeSilvio ML, Slater JD, et al: Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 294:1233-1239, 2005
18. Egger E, Zografos L, Schalenbourg A, et al: Eye retention after proton beam radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys 55:867-880, 2003
19. Dendale R, Lumbroso-Le Rouic L, Noel G, et al: Proton beam radiotherapy for uveal melanoma: Results of Curie Institut-Orsay Proton Therapy Center (ICPO). Int J Radiat Oncol Biol Phys 65:780-787, 2006
20. Hocht S, Bechrakis NE, Nausner M, et al: Proton therapy of uveal melanomas in Berlin: 5 years of experience at the Hahn-Meitner Institute. Strahlenther Onkol 180:419-424, 2004
21. Damato B, Kacperek A, Chopra M, et al: Proton beam radiotherapy of choroidal melanoma: The Liverpool-Clatterbridge experience. Int J Radiat Oncol Biol Phys 62:1405-1411, 2005
22. Courdi A, Caujolle JP, Grange JD, et al: Results of proton therapy of uveal melanomas treated in Nice. Int J Radiat Oncol Biol Phys 45:5-11, 1999
23. Fuss M, Loredo LN, Blacharski PA, et al: Proton radiation therapy for medium and large choroidal melanoma: Preservation of the eye and its functionality. Int J Radiat Oncol Biol Phys 49:1053-1059, 2001
24. Gragoudas E, Li W, Goitein M, et al: Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol 120:1665-1671, 2002
25. Wilson MW, Hungerford JL: Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology 106:1579-1587, 1999
26. Damato B, Kacperek A, Chopra M, et al: Proton beam radiotherapy of iris melanoma. Int J Radiat Oncol Biol Phys 63:109-115, 2005
27. Koyama S, Tsujii H: Proton beam therapy with high-dose irradiation for superficial and advanced esophageal carcinomas. Clin Cancer Res 9:3571-3577, 2003
28. Sugahara S, Tokuuye K, Okumura T, et al: Clinical results of proton beam therapy for cancer of the esophagus. Int J Radiat Oncol Biol Phys 61:76-84, 2005
29. Nemoto H, Tokuue K, Onishi K, et al: Proton beam therapy for large hepatocellular carcinoma. J JASTRO 16:177-182, 2004
30. Bush DA, Hillebrand DJ, Slater JM, et al: High-dose proton beam radiotherapy of hepatocellular carcinoma: Preliminary results of a phase II trial. Gastroenterology 127:S189-S193, 2004 (suppl 1)
31. Kawashima M, Furuse J, Nishio T, et al: Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. J Clin Oncol 23:1839-1846, 2005
32. Bush DA, Slater JD, Bonnet R, et al: Proton-beam radiotherapy for early-stage lung cancer. Chest 116:1313-1319, 1999
33. Nihei K, Ogino T, Ishikura S, et al: High-dose proton beam therapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 65:107-111, 2006
34. Shioyama Y, Tokuuye K, Okumura T, et al: Clinical evaluation of proton radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 56:7-13, 2003
35. Hug EB, Loredo LN, Slater JD, et al: Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 91:432-439, 1999
36. Fitzek MM, Thornton AF, Rabinov JD, et al: Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: Results of a phase II prospective trial. J Neurosurg 91:251-260, 1999
37. Fitzek MM, Thornton AF, Harsh GT, et al: Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: Results of an institutional phase I/II trial. Int J Radiat Oncol Biol Phys 51:131-137, 2001
38. Bush DA, McAllister CJ, Loredo LN, et al: Fractionated proton beam radiotherapy for acoustic neuroma. Neurosurgery 50:270-273, 2002
39. Hug EB, Muenter MW, Archambeau JO, et al: Conformal proton radiation therapy for pediatric low-grade astrocytomas. Strahlenther Onkol 178:10-17, 2002
40. Amin-Hanjani S, Ogilvy CS, Candia GJ, et al: Stereotactic radiosurgery for cavernous malformations: Kjellberg's experience with proton beam therapy in 98 cases at the Harvard Cyclotron. Neurosurgery 42:1229-1236, 1998
41. Vernimmen FJ, Harris JK, Wilson JA, et al: Stereotactic proton beam therapy of skull base meningiomas. Int J Radiat Oncol Biol Phys 49:99-105, 2001
42. Wenkel E, Thornton AF, Finkelstein D, et al: Benign meningioma: Partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys 48:1363-1370, 2000
43. Hug EB, Fitzek MM, Liebsch NJ, et al: Locally challenging osteo- and chondrogenic tumors of the axial skeleton: Results of combined proton and photon radiation therapy using three-dimensional treatment planning. Int J Radiat Oncol Biol Phys 31:467-476, 1995
44. Kagei K, Tokuuye K, Okumura T, et al: Long-term results of proton beam therapy for carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 55:1265-1271, 2003
45. Tsujii H, Akaza H, Ohtani M, et al: Preliminary results of bladder-preserving therapy with definitive radiotherapy and intraarterial infusion of chemotherapy. Strahlenther Onkol 170:531-537, 1994
46. Hata M, Miyanaga N, Tokuuye K, et al: Proton beam therapy for invasive bladder cancer: A prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy. Int J Radiat Oncol Biol Phys 64:1371-1379, 2006
47. Tai PT, Craighead P, Bagdon F: Optimization of radiotherapy for patients with cranial chordoma: A review of dose-response ratios for photon techniques. Cancer 75:749-756, 1995
48. Gay E, Sekhar LN, Rubinstein E, et al: Chordomas and chondrosarcomas of the cranial base: Results and follow-up of 60 patients. Neurosurgery 36:887-896, 1995
49. Debus J, Schulz-Ertner D, Schad L, et al: Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys 47:591-596, 2000
50. Romero J, Cardenes H, la Torre A, et al: Chordoma: Results of radiation therapy in eighteen patients. Radiother Oncol 29:27-32, 1993
51. Zorlu F, Gurkaynak M, Yildiz F, et al: Conventional external radiotherapy in the management of clivus chordomas with overt residual disease. Neurol Sci 21:203-207, 2000
52. Fuller DB, Bloom JG: Radiotherapy for chordoma. Int J Radiat Oncol Biol Phys 15:331-339, 1988
53. Forsyth PA, Cascino TL, Shaw EG, et al: Intracranial chordomas: A clinicopathological and prognostic study of 51 cases. J Neurosurg 78:741-747, 1993
54. Munzenrider JE, Liebsch NJ: Proton therapy for tumors of the skull base. Strahlenther Onkol 175:57-63, 1999 (suppl 2)
55. Noel G, Feuvret L, Calugaru V, et al: Chordomas of the base of the skull and upper cervical spine: One hundred patients irradiated by a 3D conformal technique combining photon and proton beams. Acta Oncol 44:700-708, 2005
56. Debus J, Hug EB, Liebsch NJ, et al: Brainstem tolerance to conformal radiotherapy of skull base tumors. Int J Radiat Oncol Biol Phys 39:967-975, 1997
57. Damato B: Treatment of primary intraocular melanoma. Expert Rev Anticancer Ther 6:493-506, 2006
58. Gragoudas ES, Lane AM, Munzenrider J, et al: Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc 100:43-48, 2002
59. Desjardins L, Lumbroso L, Levy C, et al: Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: Indications and comparison of local recurrence rates. J Fr Ophtalmol 26:269-276, 2003
60. Kodjikian L, Roy P, Rouberol F, et al: Survival after proton-beam irradiation of uveal melanomas. Am J Ophthalmol 137:1002-1010, 2004
61. Lumbroso L, Levy C, Plancher C, et al: Results of proton beam irradiation for treatment of choroidal melanoma. J Fr Ophtalmol 25:290-297, 2002
62. Zografos L, Egger E, Bercher L, et al: Proton beam irradiation of choroidal hemangiomas. Am J Ophthalmol 126:261-268, 1998
63. Zografos L, Bercher L, Egger E, et al: Treatment of eye tumors by accelerated proton beams: 7 years experience. Klin Monatsbl Augenheilkd 200:431-435, 1992
64. Logani S, Helenowski TK, Thakrar H, et al: Gamma knife radiosurgery in the treatment of ocular melanoma. Stereotact Funct Neurosurg 61:38-44, 1993 (suppl 1)
65. Dieckmann K, Georg D, Zehetmayer M, et al: LINAC based stereotactic radiotherapy of uveal melanoma: 4 years clinical experience. Radiother Oncol 67:199-206, 2003
66. Bellmann C, Fuss M, Holz FG, et al: Stereotactic radiation therapy for malignant choroidal tumors: Preliminary, short-term results. Ophthalmology 107:358-365, 2000
67. Langmann G, Pendl G, Klaus M, et al: Gamma knife radiosurgery for uveal melanomas: An 8-year experience. J Neurosurg 93:184-188, 2000 (suppl 3)
68. Marchini G, Gerosa M, Piovan E, et al: Gamma knife stereotactic radiosurgery for uveal melanoma: Clinical results after 2 years. Stereotact Funct Neurosurg 66:208-213, 1996 (suppl 1)
69. Tokuuye K, Akine Y, Sumi M, et al: Fractionated stereotactic radiotherapy for choroidal melanoma. Radiother Oncol 43:87-91, 1997
70. Zehetmayer M, Kitz K, Menapace R, et al: Local tumor control and morbidity after one to three fractions of stereotactic external beam irradiation for uveal melanoma. Radiother Oncol 55:135-144, 2000
71. Debus J, Fuss M, Engenhart-Cabillic R, et al: Stereotactic conforming irradiation of choroid metastases. Ophthalmologe 95:163-167, 1998
72. Pollack A, Zagars GK, Starkschall G, et al: Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53:1097-1105, 2002
73. Dearnaley DP, Hall E, Lawrence D, et al: Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer 92:488-498, 2005
74. Peeters ST, Heemsbergen WD, Koper PC, et al: Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24:1990-1996, 2006
75. Slater JD, Yonemoto LT, Mantik DW, et al: Proton radiation for treatment of cancer of the oropharynx: Early experience at Loma Linda University Medical Center using a concomitant boost technique. Int J Radiat Oncol Biol Phys 62:494-500, 2005
76. Cohen EE, Haraf DJ, List MA, et al: High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial. J Clin Oncol 24:3438-3444, 2006
77. Choi BO, Jang HS, Kang KM, et al: Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma. Jpn J Clin Oncol 36:154-158, 2006
78. Timmerman R, McGarry R, Yiannoutsos C, et al: Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24:4833-4839, 2006
79. Laperriere NJ, Leung PM, McKenzie S, et al: Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 41:1005-1011, 1998
80. Souhami L, Seiferheld W, Brachman D, et al: Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 60:853-860, 2004
81. Floyd NS, Woo SY, Teh BS, et al: Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys 58:721-726, 2004
82. Chan JL, Lee SW, Fraass BA, et al: Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 20:1635-1642, 2002
83. Shipley WU, Zietman AL, Kaufman DS, et al: Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates: The Massachusetts General Hospital and Radiation Therapy Oncology Group experiences. Semin Radiat Oncol 15:36-41, 2005
84. Hall EJ: Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65:1-7, 2006